Fmr LLC boosted its stake in shares of The Beauty Health Company (NASDAQ:SKIN – Free Report) by 0.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,603,037 shares of the company’s stock after buying an additional 58,826 shares during the period. Fmr LLC owned 0.15% of Beauty Health worth $26,788,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Caprock Group LLC acquired a new position in Beauty Health during the second quarter worth $38,000. Sanctuary Advisors LLC acquired a new position in Beauty Health during the second quarter worth $47,000. SG Americas Securities LLC acquired a new position in Beauty Health during the third quarter worth $37,000. Susquehanna Fundamental Investments LLC acquired a new position in Beauty Health during the second quarter worth $105,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in Beauty Health by 8.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 75,281 shares of the company’s stock worth $335,000 after buying an additional 5,934 shares during the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group upped their price target on Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $2.55.
Beauty Health Stock Performance
Shares of Beauty Health stock opened at $1.50 on Tuesday. The Beauty Health Company has a 52 week low of $0.91 and a 52 week high of $5.17. The business’s fifty day simple moving average is $1.58 and its 200-day simple moving average is $1.69. The firm has a market cap of $186.18 million, a PE ratio of -3.57 and a beta of 0.86. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23.
Beauty Health Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Featured Articles
- Five stocks we like better than Beauty Health
- What is the FTSE 100 index?
- How to Master Trading Discipline: Overcome Emotional Challenges
- What Investors Need to Know to Beat the Market
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- 3 Warren Buffett Stocks to Buy Now
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN – Free Report).
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.